The global Foley catheter market is expected to grow from USD 1,565 million in 2023 to USD 2,641 million by 2033, reflecting a solid CAGR of 5.4% during the forecast period. Foley catheters, used for prolonged urinary drainage in patients with various medical conditions, are a critical component of healthcare delivery, particularly in settings like hospitals, long-term care facilities, and home healthcare. With the growing prevalence of chronic conditions such as urinary incontinence, prostate disorders, and neurogenic bladder, the demand for Foley catheters is expected to rise significantly.
Several factors are contributing to the expansion of the Foley catheter market, including advancements in catheter materials and technologies, which have improved patient comfort and reduced complications associated with catheter use. Innovations such as antimicrobial coatings, latex-free materials, and smaller, more comfortable designs are making Foley catheters safer and more effective, leading to increased adoption among healthcare providers. Additionally, the aging population and the rise in chronic diseases worldwide are expected to further drive market growth, as older adults are more likely to require long-term catheterization.
The growing emphasis on patient safety, infection control, and cost-effective care in hospitals and healthcare facilities is also fueling demand for high-quality Foley catheters. As healthcare providers focus on improving patient outcomes and minimizing the risk of urinary tract infections (UTIs) and other complications, the use of advanced Foley catheters with antimicrobial properties is becoming increasingly common.
Key Takeaways:
- The Foley catheter market is projected to grow from USD 1,565 million in 2023 to USD 2,641 million by 2033, at a CAGR of 5.4%.
- The rise in chronic conditions such as urinary incontinence and prostate disorders is driving the demand for Foley catheters.
- Technological advancements, including antimicrobial coatings and latex-free materials, are enhancing the safety and comfort of Foley catheters.
- The aging population and increased focus on patient safety are key factors contributing to market expansion.
Key Growth Drivers
- Increasing Prevalence of Urinary Disorders: The rise in conditions such as urinary incontinence and benign prostatic hyperplasia is driving demand for Foley catheters.
- Aging Population: A growing elderly population is contributing to the increased need for catheterization due to age-related health issues.
- Technological Advancements: Innovations in catheter design and materials are enhancing patient comfort and reducing the risk of infections, thus promoting market growth.
Aging Population and Increasing Prevalence of Urological Disorders Drive Demand for Foley Catheters
Here are some factors that are anticipated to drive the demand for foley catheters during the forecast period.
- One of the main factors is the growing prevalence of urinary incontinence and other urological disorders. This has led to a surge in patients requiring catheterization.
- The rise in the aging population has also contributed to the growing demand for foley catheters.
- As the population ages, the incidence of urinary tract infections and other urological problems increases, further fueling the demand for catheters.
Blazing a Trail: Mapping the Fierce Terrain of Foley Catheters Industry Competition
The development of new product designs has been recognized as the key growth strategy adopted by market players to stay afloat amid cutthroat competition. On a similar note, restricting the prevalence of catheter-associated infections is likely to remain at the core strategy of innovations as manufacturers direct their efforts towards innovative designs.
On these lines, an American medical technology manufacturer, C.R. Bard, employs silver-ion and antimicrobial coatings to its product line of foley catheters to eliminate the incidence of catheter-associated infections when used for long periods.
Besides, manufacturers are seeking approvals from regulatory bodies to boost their revenue prospects and brand visibility. On this premise, Safe Medical Design Inc., a United States-based organization, procured FDA approval for the commercialization of its new product, a signal catheter.
The catheter has been designed to reduce urethral trauma as a result of premature balloon inflation during placement. Such innovations and approvals are likely to continue to boost the growth of the market.
Some recent developments in the market include
- Integer Holdings Corporation declared plans to increase its presence in Galway, Ireland in September 2021 by constructing a new manufacturing facility and a medical device invention in the Parkmore East district.
- To commercialize its urological products, Coloplast inked a three-year contract with Premier, Inc., a healthcare improvement firm based in the United States, in February 2019. Products for general urology include catheters, drainage systems, and various attachments.
Key Companies Profiled
Teleflex Incorporated; Cardinal Health; C.R Bard; B. Braun Melsungen AG; Coloplast A/S; Medtronic plc; Flume; ConvaTec Group; VOTG Medical; Sterimed Group; Ribbel International Limited; Angiplast Private Limited; Mais India Medical Devices Private Limited; and JK Medirise
Access the Full Report
Key Segments
Type:
- 2 Way
- 3 Way
- 4 Way
Material:
- Latex Foley Catheter
- Hydrogel-coated Latex Foley Catheters
- Silicon-coated Latex Foley Catheter
- Silver-coated Latex Foley Catheters
- PTFE (polytetrafluoroethylene) (Teflon)
- Coated Latex Foley Catheters
- Silicon Foley Catheter
- Hydrogel-coated Silicone Foley Catheters
- Pure Silicone Foley Catheters
- Silver-coated Silicon Foley Catheters
- Others
Indication:
- Urinary Incontinence
- Urethral Stricture
- Chronic Obstruction
- Neurogenic Bladder
- Enlarged Prostate Gland/BPH
- Prostate Cancer
- Others
End User:
- Hospitals
- Long-term Care Facilities
- Others
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
